NeuroX1
PrivateLast Round
Seed
Jun 4, 2024
Est. Valuation
$5M
Total Funding Raised
$1.96M
Company Overview
NeuroX1 is a biotechnology company that utilizes artificial intelligence and machine learning to identify disease drivers and develop small molecule therapeutics for neurological and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroX1 Comparables
Compare NeuroX1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verge Genomics | 81% | |
| Exin Therapeutics | 80% | |
| Aqemia | 77% | |
NeuroX1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 4, 2024 | ||||
| Accelerator | Mar 11, 2024 | ||||
| Seed | Mar 3, 2023 | ||||
| Pre Seed | Dec 31, 2021 |
Key People
Founding team and executive leadership
NeuroX1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Seed, Accelerator |
| Capital Factory | Seed, Pre Seed |
| Trousdale Ventures | Seed, Pre Seed |
| Vibe Capital | Pre Seed |
| Next Sequence | Accelerator, Seed |
| Drive Capital | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2023
$500K round led by Drive Capital.
- Dec 31, 2021
$1.34M round led by Drive Capital
NeuroX1 Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroX1's valuation, stock price, and market status.